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Abstract  The collapse of South Asia’s Gyps vulture populations is attributable to the 31 
veterinary use of the non-steroidal anti-inflammatory drug (NSAID) diclofenac.  Vultures 32 
died after feeding on carcasses of recently-medicated animals.  The governments of India, 33 
Nepal and Pakistan banned the veterinary use of diclofenac in 2006.  We analysed results of 34 
62 necropsies and 48 NSAID assays of liver and/or kidney for vultures of five species found 35 
dead in India between 2000 and 2012.  Visceral gout and diclofenac were detected in 36 
vultures from nine states and three species: Gyps bengalensis, G. indicus and G. himalayensis. 37 
Visceral gout was found in every vulture carcass in which a measurable level of diclofenac 38 
was detected.  Meloxicam, an NSAID of low toxicity to vultures, was found in two vultures 39 
and nimesulide in five vultures. Nimesulide at elevated tissue concentrations was associated 40 
with visceral gout in four of these cases, always without diclofenac, suggesting that 41 
nimesulide may have similar toxic effects to those of diclofenac. Residues of meloxicam on 42 
its own were never associated with visceral gout.  The proportion of Gyps vultures found 43 
dead in the wild in India with measurable levels of diclofenac in their tissues showed a 44 
modest and non-significant decline since the ban on the veterinary use of diclofenac. The 45 
prevalence of visceral gout declined less, probably because some cases of visceral gout from 46 
2008 onwards were associated with nimesulide rather than diclofenac. Veterinary use of 47 
nimesulide is a  potential threat to the recovery of vulture populations. 48 
 49 
Keywords diclofenac, environmental pollution, Gyps, meloxicam, nephrotoxicity, 50 
nimesulide, non-steroidal anti-inflammatory drug, vulture 51 
 52 
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Introduction 54 
 55 
Populations of three species of Gyps vultures endemic to South Asia fell by more than 97% 56 
between the early 1990s and 2007 (Prakash et al., 2003; 2007; 2012), leading to their being 57 
classified as Critically Endangered in the IUCN Red List in 2000 (BirdLife International, 58 
2014). Research has established that veterinary use of diclofenac, a non-steroidal anti-59 
inflammatory drug (NSAID), was the principal cause of this collapse in vulture numbers 60 
(Oaks et al., 2004; Green et al., 2004; Shultz et al., 2004; Green et al., 2007).  Diclofenac is 61 
nephrotoxic at low doses to all species of Gyps vultures tested (Oaks et al., 2004; Swan et al., 62 
2006a). Residues of the drug were found in carcasses of domesticated ungulates available to 63 
vultures in India (Green et al., 2007; Taggart et al., 2007; 2009) and vultures were exposed 64 
when they consumed carcasses of ungulates treated shortly before death (Oaks et al., 2004; 65 
Green et al., 2006). Post-mortem examination of Gyps vultures killed by diclofenac poisoning 66 
in experiments showed extensive visceral gout and necrosis of kidney tissues similar to that 67 
seen in a high proportion of vultures found dead in the wild (Oaks et al., 2004; Shultz et al., 68 
2004; Meteyer et al., 2005; Swan et al., 2006a). Bans on the veterinary use of diclofenac have 69 
been in force since 2006 in India, Pakistan and Nepal, and since 2010 in Bangladesh. The 70 
safety to Gyps vultures of meloxicam, an alternative veterinary NSAID, has been established 71 
experimentally (Swan et al., 2006b; Swarup et al., 2007). In India, the proportion of ungulate 72 
carcasses contaminated with diclofenac fell by about half within four years of the 73 
introduction of the ban (Cuthbert et al., 2014).  In association with this decrease in diclofenac 74 
prevalence, the rate of decline of Gyps vulture populations in India, Nepal and Pakistan has 75 
slowed (Jamshed et al., 2012; Prakash et al., 2012), as has the decline in two other vulture 76 
species, red-headed vulture Sarcogyps calvus and Egyptian vulture Neophron percnopterus, 77 
which may also be affected by diclofenac (Galligan et al., 2014). 78 
In this paper, we report the findings of necropsies of dead vultures collected in India 79 
between 2000 and 2012, which includes periods before and after the diclofenac ban in 2006. 80 
We re-evaluate the previously observed perfect association of visceral gout with diclofenac 81 
and other NSAIDs by comparing necropsy results with measurements of the concentrations 82 
of nine NSAIDs in liver and/or kidney.  We evaluate changes over time in the prevalence of 83 
visceral gout and NSAID contamination in carcasses of vultures found dead in the wild. 84 
 Vulture deaths and NSAIDs Page 4 
 85 
Materials and methods 86 
 87 
Collection of vulture carcasses 88 
 89 
Carcasses of vultures were collected from July 2000 to April 2012 in nine states of India 90 
(Assam, Gujarat, Haryana, Himachal Pradesh, Jharkhand, Madhya Pradesh, Maharashtra, 91 
Rajasthan and Uttarakhand), extending from the western to the eastern extremes of the 92 
country.  We report here only results for specimens for which the year of collection was 93 
known and results of necropsy, NSAID assay or both were available.  A total of 62 vultures 94 
was examined at necropsy for visceral gout (1 cinereous vulture Aegypius monachus, 1 95 
Eurasian griffon vulture Gyps fulvus, 3 Himalayan griffon vulture G. himalayensis, 17 long-96 
billed vulture G. indicus and 40 oriental white-backed vulture G. bengalensis).   Liver and/or 97 
kidney samples from 48 vultures were assayed for NSAIDs (1 A. monachus, 1 G. fulvus, 3 G. 98 
himalayensis, 10 G. indicus and 33 G. bengalensis).  Carcasses of 47 vultures (1 A. monachus, 1 G. 99 
fulvus, 3 G. himalayensis, 10 G. indicus and 32 G. bengalensis) were assessed for both gout and 100 
NSAIDs. No NSAID assays were available for seven G. indicus and eight G. bengalensis with 101 
necropsy results and one G bengalensis with an NSAID assay did not have a necropsy result. 102 
Vulture carcasses were collected by staff of the Bombay Natural History Society and 103 
volunteers, local conservation NGOs and individuals.  Two carcasses of G. bengalensis were 104 
obtained as a result of special efforts to collect and treat the large numbers of birds killed 105 
and injured by collisions with kite strings during the annual kite-flying festival in the city of 106 
Ahmedabad (Gujarat), but the others were found opportunistically, dead or dying in the 107 
field.  After their population decline became apparent, vultures in India were strictly 108 
protected under Schedule I of the Wildlife Protection Act (1972), which requires permits 109 
before live or dead specimens can be collected.  This restriction influenced both the number 110 
of carcasses obtained and the distribution of collection localities.  Our study included all 23 111 
vulture carcasses collected in India for which data were reported by Shultz et al. (2004). 112 
 113 
  114 
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Necropsies of vulture carcasses and assessment of visceral gout 115 
 116 
Detailed necropsy examinations were undertaken by trained veterinarians and field 117 
biologists who followed a standard protocol (Cunningham et al., 2003). This included 118 
external and internal visual examination for gross abnormalities and the collection of liver 119 
and/or kidney tissues for subsequent NSAID residue analysis. Where possible, morbid 120 
tissues fixed in 10% NBF were processed by a conventional technique to obtain 4 µm thick 121 
paraffin embedded sections (Luna, 1972). The sections stained with routine hematoxylin and 122 
eosin (HE) stain were examined under a trinocular microscope with attached camera (Leica 123 
Microsystems, Wetzlar) for pathological changes associated with nephrotoxicity. De 124 
Galantha stain was employed for demonstration of urate crystals. Images of representative 125 
changes were documented.  Samples of kidney and/or liver were removed and frozen for 126 
NSAID assays. 127 
In some cases, when carcasses were found in remote locations or where trained personnel 128 
were not available, full necropsies could not be performed and less detailed examinations 129 
were conducted in the field. We consider these examinations, together with the detailed post 130 
mortems, sufficient for the detection of the presence or absence of visceral gout based upon 131 
observation of white crystals of uric acid deposited on the surfaces of organs such as the 132 
liver (see Oaks et al. (2004) and Swan et al. (2006a) for illustrations).  In reviewing the post-133 
mortem reports, we found two cases of white deposits on internal organs, like those seen in 134 
gout, in which this was considered at the time to be possibly due to an unidentified fungal 135 
infection in one case and candidiasis (a specific fungal infection) in another. In both cases, 136 
fungal infection was not confirmed by microscopy.  In the case of the bird with suggested 137 
candidiasis, subsequent histopathological examination of the kidney revealed severe gout 138 
nephrosis.  This suggested that white deposits observed on macroscopic examination had 139 
been misidentified as fungal infection.  We therefore judged that gout had been mistakenly 140 
identified as fungal disease in both cases and reassigned both as having visceral gout. 141 
 142 
  143 
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Measurement of NSAID residues 144 
 145 
Samples of frozen liver and kidney (~0.5 g) were thawed and weighed (to ± 1 mg) into new 146 
glass test tubes and homogenized with 2 ml of HPLC grade acetonitrile using an Ultra 147 
Turrax IKA T8 handheld homogenizer. This mixture was then centrifuged at 1000 g for 5 148 
min and the supernatant filtered using disposable PTFE syringe filter units of 0.45 micron. 149 
The filtered extract was stored in crimp top LC vials at -20°C until analysis. Samples 150 
collected up until June 2004 were analysed for diclofenac only by LC–ESI/MS (liquid 151 
chromatography–electrospray ionisation mass spectrometry) using an Agilent 1100 LC and 152 
1946D MS, following methods in Taggart et al. (2007). The limit of quantification (LOQ) for 153 
this technique (back-calculated to wet tissue concentration) was 0.01 mg kg-1. Samples 154 
collected after June 2004 were analysed for nine different veterinary NSAIDs that were 155 
selected based on their potential risk to avian species, presence within pharmacies in India, 156 
and likelihood to enter the veterinary sector in the region (Taggart et al., 2009; Cuthbert et al., 157 
2011). These NSAIDs were carprofen, diclofenac, flunixin, ibuprofen, indometacin, 158 
ketoprofen, meloxicam, naproxen and nimesulide. They were analysed by LC–ESI/MS in 159 
negative ion mode (utilizing a C18 column) following methods described in Taggart et al. 160 
(2009). LOQ values for these nine NSAIDs ranged from 0.005 to 0.02 mg kg-1 (see Table S1 of 161 
Taggart et al., 2009).  The LOQ for diclofenac was the same (0.01 mg kg-1) in the analyses 162 
conducted before and after June 2004.  Of the 48 carcasses for which diclofenac 163 
measurements were made, values were available for both liver and kidney for 37 carcasses, 164 
liver only for eight carcasses and kidney only for three carcasses. 165 
 166 
Statistical analysis 167 
 168 
The statistical significance of associations between the presence of gout and the detection of 169 
diclofenac residues in liver and/or kidney was assessed using the Fisher exact test for a 2x2 170 
contingency table (Siegel & Castellan 1988).  The two-tailed exact probability was calculated 171 
for the observed outcome under a null hypothesis of no association. 172 
We estimated trends over time in the prevalence of diclofenac residues in the liver 173 
and/or kidney and the prevalence of visceral gout in vultures by logistic regression analysis 174 
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(Crawley, 2007) with the presence/absence of diclofenac contamination or the 175 
presence/absence of gout as binary dependent variables and calendar year of collection as an 176 
independent variable.  It was necessary to allow for species and age class in these analyses 177 
because previous studies have indicated that the prevalence of both gout and diclofenac 178 
contamination of Gyps vultures in the Indian subcontinent vary with those variables. Both 179 
prevalences tend to be higher in G. bengalensis than in G. indicus (Shultz et al., 2004, Green et 180 
al., 2004) and higher in adults than immatures (Gilbert et al., 2002; Green et al., 2004).  For 181 
example, in a large sample of G. bengalensis found dead in Pakistan, the prevalence of 182 
visceral gout increased progressively with age, being 13% in nestlings, 19% in fledglings, 183 
63% in sub-adults and 80% in adults (Gilbert et al., 2002). 184 
The proportions of carcasses for different Gyps species changed over time. For 185 
example, after 2004 a larger proportion of the carcasses examined were of Gyps bengalensis 186 
rather than G. indicus (Table 1).  Given that the prevalence of gout and diclofenac tended to 187 
be higher in G. bengalensis than in G. indicus when the species are compared during the same 188 
period (see above), ignoring the change over time in species composition in the regression 189 
analysis would bias the estimated trend to be more positive (less negative) than it should be. 190 
The proportion of adult vultures in the sample examined was slightly higher after 191 
2004 than it was before (Table 1), and this would tend to bias the trend in the opposite 192 
direction.  To allow for these differences, we fitted multiple logistic regression models with 193 
the main effects of species (Gyps himalayensis, G. indicus and G. bengalensis) and age class 194 
(nestling, immature [i.e. juvenile and sub-adult] and adult) each included as three-level 195 
factors in addition to time (collection year) as a continuous variable.  196 
We excluded from the logistic regression models the results for the single specimens 197 
of Aegypius monachus and Gyps fulvus because the small sample size for these species did not 198 
allow us to fit reliable statistical models of the effects of species differences. We also 199 
excluded results for two Gyps bengalensis carcasses whose recovery was associated with a 200 
kite festival (see above).  Carcasses whose age class was not recorded were also excluded 201 
(six carcasses from the gout dataset and two carcasses from the diclofenac dataset). 202 
We expected that the prevalence of diclofenac contamination and visceral gout 203 
would decline with increasing time during this period, based upon independent information 204 
on the downward trend in diclofenac contamination of ungulates (Cuthbert et al., 2014). 205 
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Hence, we used one-tailed t-tests in these analyses to assess the statistical significance of 206 
trends over time.  To display our results graphically, we plotted the expected proportions 207 
from the models against time for adult G. bengalensis and adult G. indicus. 208 
 209 
Comparison with the change in proportion of diclofenac-contaminated vulture 210 
carcasses expected from the results of surveys of diclofenac in ungulate livers 211 
 212 
We calculated the expected probability of death caused by diclofenac per vulture meal C in 213 
mid-2005 and the annual survival rate of adults in the absence of diclofenac using the 214 
simulation model of a vulture population described by Green et al., (2004).  We obtained 215 
values of C and survival that gave a value for the annual rate of population decline for Gyps 216 
bengalensis in India equal to the value observed at that time (population multiplication rate λ 217 
= 0.520; (Green et al., 2004) and a value for the proportion of dead adult G. bengalensis with 218 
diclofenac in mid-2005 equal to that from the multiple logistic regression fitted to post-219 
mortem data (see preceding section), which was 85.2%.  We then estimated C for mid-2009 220 
by reducing the mid-2005 estimate by 66%, which is the change in this parameter estimated 221 
for the four-year period 2005 - 2009 from the surveys of diclofenac concentrations in liver 222 
samples of ungulate carcasses available to vultures in India by Cuthbert et al. (2014).   We 223 
used the method given by Green et al. (2004) to calculate the expected proportion of deaths 224 
of adult G. bengalensis caused by diclofenac in mid-2009 from this reduced mid-2009 value of 225 
C.  We obtained confidence limits for this expected proportion from the bootstrap 226 
confidence limits for the change in expected death rate per meal given by Cuthbert et al. 227 
(2014) (see their Table 2).  We performed a significance test of the difference between the 228 
expected proportion of deaths of adult G. bengalensis caused by diclofenac in mid – 2009 229 
based upon vulture necropsies and the estimate of the same quantity derived from the 230 
surveys of diclofenac in ungulate livers.  To do this we generated lists of 10,000 bootstrap 231 
estimates of the proportions of vultures with diclofenac for each of the two methods. We 232 
aligned the two randomly-ordered lists, calculated the absolute difference between values 233 
for each pair of bootstrap replicates and took the proportion of replicates in which the 234 
difference had the opposite sign to that observed in the real data to be the probability of 235 
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observing by chance a difference as large or larger as that obtained from the original 236 
calculations. 237 
 238 
Results 239 
 240 
Prevalence of visceral gout 241 
 242 
Visceral gout was not present in either of the single Aegypius monachus and Gyps fulvus 243 
carcasses examined. In the other three species, the overall proportions with gout were 33% 244 
for G. himalayensis (1/3), 53% for G. indicus (9/17) and 73% for G. bengalensis (29/40). 245 
 246 
Co-occurrence of visceral gout and NSAID residues in the liver and/or kidney 247 
 248 
During the period 2000 – 2004, when diclofenac was the only NSAID being measured, 249 
diclofenac residues were present in liver and/or kidney tissue in all Gyps vulture carcasses in 250 
which visceral gout was identified, and in none of the carcasses with no gout (Table 1). This 251 
perfect association between diclofenac and visceral gout is highly significant (Fisher exact 252 
test P < 0.0001).  In the later period 2005 – 2011, in which other NSAIDs were also assayed in 253 
addition to diclofenac, all Gyps vulture carcasses with diclofenac residues also had visceral 254 
gout and no carcasses without gout had diclofenac. However, four of the 16 carcasses with 255 
gout did not have measurable levels of diclofenac, but did have residues of other NSAIDs 256 
(Table 1).  All four of these carcasses had nimesulide in both the liver and kidney and one of 257 
them had meloxicam, as well as nimesulide, in both tissues.  Of eight carcasses without gout, 258 
one had very low residues of nimesulide and one had residues of meloxicam (Table 1).  259 
Hence, during the period 2005 – 2011 the perfect association between diclofenac and gout 260 
found in the earlier period became weaker, though it remained statistically significant 261 
(Fisher exact test P = 0.0013). A logistic regression analysis of the 29 vulture carcasses with 262 
gout, in which the presence/absence of diclofenac was the binary dependent variable and 263 
year of collection was the independent variable, suggested a tendency for the proportion of 264 
vulture carcasses with gout that had no diclofenac residues to increase over time, but this 265 
trend was not statistically significant (t27 = 1.48, P = 0.15). 266 
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 267 
Concentrations of NSAIDs in liver and kidney of vultures 268 
 269 
In the 37 vulture carcasses for which diclofenac assays were performed for both liver and 270 
kidney, diclofenac was detected above the limit of quantification in both tissues in all 17 271 
cases in which it was detected in either tissue, and was below the limit of quantification in 272 
both tissues in the remaining 20 cases. In the 17 cases with diclofenac above the LOQ in both 273 
tissues, there was a significant positive correlation between the concentrations in liver and 274 
kidney (r = 0.663, t15 = 3.43, P = 0.003, Appendix Figure S1). The arithmetic means of the 275 
concentrations of diclofenac in liver and kidney in this subset of individuals were similar 276 
and not significantly different (liver, mean 0.181 mg kg-1, range 0.010 – 0.797 mg kg-1; kidney, 277 
mean 0.253 mg kg-1; range 0.010 – 0.872 mg kg-1; Wilcoxon signed ranks test, P = 0.124). 278 
In the five vulture carcasses in which nimesulide was detected, levels were above the 279 
limit of quantification in both liver and kidney (Table 2). There was a weak and non-280 
significant positive correlation between the nimesulide concentrations in the liver and 281 
kidney (r = 0.491, t3 = 0.97, P = 0.402, Appendix Figure S2).  Four of the five carcasses with 282 
measurable residues of nimesulide had visceral gout. The carcass with nimesulide and no 283 
gout had low concentrations of nimesulide near to the limit of quantification in both tissues, 284 
whilst the four birds with gout had considerably higher concentrations in one or both tissues 285 
(Table 2).  In the two vulture carcasses in which meloxicam was detected, it was above the 286 
limit of quantification in both liver and kidney.  In one of these carcasses there was visceral 287 
gout, but the concentration of meloxicam was very low in both liver and kidney whilst the 288 
concentration of nimesulide in both tissues was very high.  The other carcass with 289 
meloxicam had high concentrations of the drug in both liver and kidney but no sign of 290 
visceral gout (Table 2). Meloxicam was the only NSAID detected in this bird. 291 
 292 
Changes over time in the prevalence of diclofenac and visceral gout 293 
 294 
Logistic regression analysis of the trend in the prevalence of diclofenac in liver and/or 295 
kidneys of vultures indicated a decline that was close to statistical significance (Figure 1).  In 296 
a multiple regression model with effects of species and age accounted for, the logarithm of 297 
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the odds of a vulture carcass having a measurable level of diclofenac declined by 0.2019 per 298 
year (1 S.E. = 0.1246, t36 = 1.620, one-tailed P = 0.057).  The proportion of adult Gyps 299 
bengalensis expected from the regression model to have measurable level of diclofenac fell 300 
from 85% in the middle of 2005, just before the diclofenac ban, to 72% four years later in 301 
mid-2009 (Figure 1).  For G. indicus, the equivalent change was from 77% to 59%. 302 
Logistic regression analysis of the trend in the prevalence of visceral gout indicated a 303 
non-significant decline at a slower rate than that for diclofenac (Figure 2).  In a multiple 304 
regression model with effects of species and age accounted for, the logarithm of the odds of 305 
a vulture carcass having gout declined by 0.1289 per year (1 S.E. = 0.1038, t36 = 1.242, one-306 
tailed P = 0.110).  The proportion of adult Gyps bengalensis expected from the regression 307 
model to have gout fell from 88% in the middle of 2005 to 82% four years later in mid-2009 308 
(Figure 2).  For G. indicus, the equivalent change was from 61% to 48%. 309 
 310 
Comparison of the decline in diclofenac prevalence in vulture carcasses with the 311 
decline expected from surveys of diclofenac in ungulate carcasses 312 
 313 
The expected vulture death rate per meal estimated from surveys of diclofenac residues in 314 
liver samples from ungulate carcasses declined by 66% in the four years between mid-2005 315 
and mid-2009 (see Table 2 of Cuthbert et al., (2014)).  This change in expected death rate per 316 
meal, when used in the vulture population model of Green et al. (2004) (see Materials and 317 
Methods), gave an expected proportion of deaths of adult G. bengalensis caused by diclofenac 318 
in mid – 2009 of 62.0% (95% confidence limits 41.5 – 72.2%). The estimated proportion of 319 
adult Gyps bengalensis carcasses with diclofenac in mid-2009 derived from the logistic 320 
regression model of vulture necropsy results was 71.9% (95% C.L. 48.2% - 87.5%) whereas 321 
the same proportion derived from the surveys of diclofenac in ungulate carcasses was 62.0%, 322 
if it is assumed in both cases that the proportion of vulture carcasses with diclofenac in mid-323 
2005 was 85.2% (Figure 1).  The decline in the proportion of vulture carcasses with 324 
diclofenac derived from vulture necropsies was smaller than that derived from diclofenac 325 
surveys of ungulate carcasses (85.2% to 71.9% cf. 85.2% to 62.0% respectively).  However, the 326 
difference between the estimates derived from the two methods does not approach 327 
statistical significance (bootstrap P = 0.201). 328 
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 329 
Discussion 330 
 331 
Our results indicate that diclofenac remained a significant cause of mortality for India’s 332 
vultures and that the drug has continued to kill birds long after the 2006 regulations to 333 
prevent its veterinary use.  The proportion of Gyps vultures found dead in the wild in India 334 
that had measurable levels of diclofenac in their tissues showed only a small and non-335 
significant decline in the five years since the ban on the veterinary use of diclofenac covered 336 
by our study.  The estimated size of the decline was broadly consistent with an independent 337 
estimate based upon measurements of the change in the prevalence and concentration of 338 
diclofenac in carcasses of domesticated ungulates available to vultures (Cuthbert et al., 2014).  339 
Continued mortality of vultures in India caused by diclofenac after the ban, is consistent 340 
with the continued availability of the drug in pharmacies. Based upon surveys conducted 341 
between November 2007 and June 2010 in eleven Indian states, Cuthbert et al. (2011) 342 
reported that diclofenac formulated for non-veterinary use was offered for sale for 343 
veterinary use in 36% of pharmacies that sold any type of NSAID. 344 
All vultures with measurable diclofenac in liver and/or kidney had visceral gout and 345 
this association was highly statistically significant.  Wild Asian Gyps vultures that died with 346 
visceral gout and with measurable diclofenac in their tissues in our study had similar 347 
concentrations of diclofenac in the kidney to those that died in similar circumstances in the 348 
study of Oaks et al. 2004). Means and ranges were similar in our study of wild G. bengalensis 349 
and G. indicus carcasses from India (mean = 0.253 mg kg-1; range = 0.010 – 0.872 mg kg-1), the 350 
study of Oaks et al. (2004) of wild G. bengalensis carcasses from Pakistan (mean = 0.271 mg 351 
kg-1; range = 0.064 – 0.642 mg kg-1) and the study of Oaks et al. (2004) of captive G. bengalensis 352 
that died after experimental administration of meat from water buffalo or goat given a 353 
veterinary dose of diclofenac shortly before death (mean = 0.388 mg kg-1; range = 0.070 – 354 
0.906 mg kg-1).  We therefore consider that that diclofenac was likely to have been the cause 355 
of death of all of the vultures reported in the present study in which the drug was detected 356 
at above the limit of quantification. 357 
The estimated decline in the prevalence of visceral gout in Gyps vultures found dead 358 
in India was smaller than that for diclofenac prevalence, and did not approach statistical 359 
 Vulture deaths and NSAIDs Page 13 
significance.  This may be because cases of visceral gout that were not associated with the 360 
presence of diclofenac in liver and/or kidney tissues began to occur from 2008 onwards. 361 
Four Gyps bengalensis with gout collected in 2008 – 2011 had no measurable diclofenac, but 362 
all had high concentrations of nimesulide in the liver and/or kidney.  One of these carcasses 363 
also contained meloxicam residues, but at concentrations so low that involvement of 364 
meloxicam in the death of the bird is unlikely. Another G. bengalensis carcass had a very low 365 
concentration (near LOQ) of nimesulide in both liver and kidney and no visceral gout.  366 
Hence, wild vultures in India are being exposed to nimesulide. Exposure at a high level is 367 
associated with visceral gout and death. Reddy et al. (2006) suggested that nimesulide is 368 
likely to be safe for vultures, based upon a comparison of the toxicity of nimesulide and 369 
diclofenac to domestic fowl Gallus domesticus. However, there are large differences in the 370 
toxicity of NSAIDs among bird species (Cuthbert et al. 2006), so the safety of nimesulide in 371 
domestic fowl cannot be taken to indicate its safety to distantly-related vultures. 372 
Nimesulide is legally approved for veterinary use in India and was offered for sale 373 
for this purpose in 48% of pharmacies that sold any type of NSAID in surveys conducted in 374 
2007 - 2010 in eleven Indian states (Cuthbert et al., 2011). The prevalence of nimesulide in 375 
pharmacies was particularly high in Gujarat, where it was offered for sale for veterinary use 376 
in 80% of shops visited (28 out of 35 shops; R.J. Cuthbert unpublished data). It is therefore 377 
notable that all four vultures with both nimesulide residues and visceral gout were collected 378 
from Gujarat. However, there is little evidence of nimesulide in carcasses of domesticated 379 
ungulates in India.  Taggart et al. (2009) did not find any nimesulide residues in liver 380 
samples from 1,488 ungulate carcasses collected between April and December 2006. After 381 
including further samples collected up until July 2010 (total n = 3,150), only three ungulate 382 
carcasses with low (< 0.04 mg kg-1) levels of nimesulide were found (0.1 (M.A. Taggart, 383 
unpublished data).  384 
Comparison of the time to maximum plasma concentration (tmax) and elimination 385 
half-life (T1/2) of nimesulide in cattle following intramuscular injection shows that its 386 
pharmacokinetics are broadly similar to those of diclofenac (EMEA 2003; Mahapatra et al., 387 
2009). Hence, the elimination of nimesulide in cattle is unlikely to be much more rapid than 388 
for diclofenac.  To date, the liver has been the only organ routinely sampled in surveys of 389 
NSAIDs in ungulate carcasses in India (Taggart et al., 2007, 2009; Cuthbert et al., 2014). 390 
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Nimesulide concentrations in ungulate livers might be unusually low relative to other 391 
tissues.  Alternatively, the exposure pathway for vultures might involve sources of carrion 392 
that have not been surveyed, such as poultry waste.  These questions should be addressed 393 
through further field sampling and experiments to study tissue distribution of nimesulide in 394 
ungulates. 395 
Another NSAID found in vulture carcasses was meloxicam, which is the only drug 396 
established by experiment to be of low toxicity to Gyps vultures and other scavenging birds 397 
(Swan et al., 2006b; Cuthbert et al., 2007; Swarup et al., 2007).  One vulture carcass with 398 
visceral gout had a low concentration of meloxicam and a high concentration of nimesulide 399 
in liver and kidney tissues, as described above.  Another vulture carcass had a high 400 
concentration of meloxicam in liver and kidney and no trace of any other NSAID, and it had 401 
no evidence of gout.  The cause of death of this bird was recorded to be diphtheroid 402 
enteritis.  Therefore our findings are consistent with the safety to vultures of veterinary use 403 
of meloxicam indicated by experimental studies on captive birds. However, carcasses of 404 
wild vultures should continue to be monitored to check that this is the case under field 405 
conditions. 406 
The NSAIDs carprofen, flunixin, ibuprofen, indometacin, ketoprofen, and naproxen 407 
were not detected in any of the 25 vulture carcasses assayed for them.  In experiments on the 408 
African vultures Gyps coprotheres and G. africanus, ketoprofen has been shown to be 409 
nephrotoxic at doses that are likely to be encountered by wild vultures (Naidoo et al., 2010). 410 
A wild Gyps fulvus was recently found dead in Spain with visceral gout associated with high 411 
levels of flunixin residues in liver and kidney tissues (Zorilla et al., 2014). This augments 412 
previous evidence that flunixin may be nephrotoxic to Gyps vultures from surveys of the 413 
therapeutic use of NSAIDs on captive vultures in zoos, rehabilitation centres and other 414 
collections (Cuthbert et al., 2007).  This survey also found evidence of nephrotoxicity of 415 
carprofen in one Gyps vulture.  Experiments on captive vultures to measure the toxicity of 416 
flunixin and carprofen have not yet been conducted. 417 
Taggart et al. (2009) found that some liver samples from domesticated ungulates 418 
available to vultures in India between April and December 2006 contained residues of 419 
ibuprofen and ketoprofen, but flunixin was not detected (Table 2 in Taggart et al., 2009).  In 420 
surveys conducted in 2007 - 2010 in eleven Indian states by Cuthbert et al. (2011), flunixin 421 
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was being offered for sale for veterinary use in 7% of pharmacies that sold any type of 422 
NSAID, ibuprofen in 32%, and ketoprofen in 29%.  The fact that we did not find residues of 423 
these drugs in the sample of 25 vulture carcasses assayed for them may reflect the small size 424 
of our sample rather than their true absence from vulture carcasses.  There is a 5% 425 
probability of our survey finding no contamination with any of these drugs, even if the true 426 
prevalence of the drugs in vulture carcasses had been as high as 11% ((1-0.113)25 = 0.05). 427 
Our study highlights the continuing threat to Asia’s vultures from veterinary use of 428 
diclofenac and identifies a new potential threat from nimesulide.  Toxicity testing of 429 
nimesulide on Gyps vultures is needed to establish whether or not the compound is 430 
nephrotoxic.  Illegal misuse in the veterinary sector of diclofenac products labelled “for 431 
human use only” is the cause of much of the ongoing threat from that drug and further 432 
action to eliminate this is recommended (Cuthbert et al., 2011).  Identification of NSAIDs 433 
which are effective on cattle and also safe for vultures at the maximum likelihood exposure 434 
level would be valuable for vulture conservation, but so far the only known example of such 435 
a drug is meloxicam. 436 
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TABLE 1. Co-occurrence of visceral gout and residues of NSAIDs in carcasses of wild Gyps vultures collected in 
India in 2000 – 2011.  Results are shown separately for a period when NSAID assays were only performed for 
diclofenac (2000 – 2004) and a later period (2005 – 2011) when carprofen, flunixin, ibuprofen, indometacin, 
ketoprofen, meloxicam, naproxen and nimesulide were also assayed.  For these additional drugs, only residues 
of nimesulide and meloxicam were detected.  Numbers of nestlings, immature, adults and birds of unknown age 
respectively are shown in brackets. 
 
Period Species Gout Diclofenac Nimesulide Meloxicam Nimesulide 
& 
Meloxicam 
No 
diclofenac 
2000 - 2004 G. fulvus Yes 0  -  -  - 0 
  No 0  -  -  - 1 (0,1,0,0) 
        
 G. himalayensis Yes 0  -  -  - 0 
  No 0  -  -  - 1 (0,1,0,0) 
        
 G. indicus Yes 6 (0,5,1,0)  -  -  - 0 
  No 0  -  -  - 3 (0,2,1,0) 
        
 G. bengalensis Yes 7 (0,3,4,0)  -  -  - 0 
  No 0  -  -  - 4 (1,1,2,0) 
        
 All species Yes 13 (0,8,5,0)  -  -  - 0 
  No 0  -  -  - 9 (1,5,3,0) 
        
Period Species Gout Diclofenac Nimesulide Meloxicam Nimesulide 
& 
Meloxicam 
No NSAID 
2005 - 2011 G. fulvus Yes 0 0 0 0 0 
  No 0 0 0 0 0 
        
 G. himalayensis Yes 1 (0,1,0,0) 0 0 0 0 
  No 0 0 0 0 1 (0,1,0,0) 
        
 G. indicus Yes 0 0 0 0 0 
  No 0 0 0 0 1 (0,1,0,0) 
        
 G. bengalensis Yes 11 (2,1,8,0) 3 (0,1,1,1) 0 1 (0,0,1,0) 0 
  No 0 1 (0,0,1,0) 1 (0,0,0,1) 0 4 (1,3,0,0) 
        
 All species Yes 12 (2,2,8,0) 3 (0,1,1,1) 0 1 (0,0,1,0) 0 
  No 0 1 (0,0,1,0) 1 (0,0,0,1) 0 6 (1,5,0,0) 
 
 568 
  569 
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TABLE 2. Concentrations (mg kg-1) of nimesulide and meloxicam and the presence of 
visceral gout in all carcasses in which either or both of these drugs was detected.  All 
six vultures were Gyps bengalensis.  Other NSAIDs (diclofenac, carprofen, flunixin, 
ibuprofen, indometacin, ketoprofen and naproxen) were assayed in all of these birds, 
but none was detected. <LOQ means below the limit of quantification of the assay. 
 
   Nimesulide Meloxicam  
Age class State Collection 
year 
Liver Kidney Liver Kidney Visceral 
gout? 
Adult Gujarat 2008 0.309 2.753 < LOQ < LOQ Yes 
Juvenile Gujarat 2010 0.297 0.014 < LOQ < LOQ Yes 
Adult Jharkhand 2010 0.010 0.014 < LOQ < LOQ No 
Unknown Gujarat 2010 < LOQ < LOQ 0.187 0.684 No 
Unknown Gujarat 2011 0.156 0.689 < LOQ < LOQ Yes 
Adult Gujarat 2011 0.573 1.459 0.019 0.028 Yes 
 570 
 571 
  572 
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Figure Captions 573 
 574 
FIG. 1. Proportions of carcasses of wild adult Gyps bengalensis (solid curve) and G. indicus 575 
(dashed curve) contaminated with diclofenac, in relation to the year of collection. Curves 576 
represent expected values from a logistic regression model that included the main effects of 577 
species, age class and year.   Symbols show the expected  proportions of adult  G. bengalensis 578 
contaminated with diclofenac in mid - 2005 (circle) and mid - 2009 (triangle) from the data 579 
from vulture carcasses, and the expected  proportion of adult  G. bengalensis deaths caused 580 
by diclofenac in mid - 2009 (square) based upon the results of surveys of diclofenac 581 
contamination of carcasses of domesticated ungulates.  Vertical lines represent 95% 582 
confidence limits. 583 
 584 
FIG. 2. Proportions of carcasses of wild adult Gyps bengalensis (solid curve) and G. indicus 585 
(dashed curve) with visceral gout, in relation to the year of collection. Curves represent 586 
expected values from a logistic regression model that included the main effects of species, 587 
age class and year.   588 
  589 
 Vulture deaths and NSAIDs Page 24 
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
P
ro
p
o
rt
io
n
Year
 590 
 591 
  592 
FIG. 1. Proportions of carcasses of wild adult Gyps bengalensis (solid curve) and G. 
indicus (dashed curve) contaminated with diclofenac, in relation to the year of 
collection. Curves represent expected values from a logistic regression model that 
included the main effects of species, age class and year.   Symbols show the expected  
proportions of adult  G. bengalensis contaminated with diclofenac in mid - 2005 (circle) 
and mid - 2009 (triangle) from the data from vulture carcasses, and the expected  
proportion of adult  G. bengalensis deaths caused by diclofenac in mid - 2009 (square) 
based upon the results of surveys of diclofenac contamination of carcasses of 
domesticated ungulates.  Vertical lines represent 95% confidence limits. 
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FIG. 2. Proportions of carcasses of wild adult Gyps bengalensis (solid curve) and G. 
indicus (dashed curve) with visceral gout, in relation to the year of collection. Curves 
represent expected values from a logistic regression model that included the main 
effects of species, age class and year. 
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Continuing mortality of vultures in India associated with 620 
illegal veterinary use of diclofenac and a possible threat from 621 
nimesulide 622 
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Appendix Figure S1. 630 
 631 
 632 
 633 
 634 
  635 
Figure S1. Concentrations (mg kg-1) of diclofenac in samples of kidney and 
liver tissue from the same bird for all 17 vultures in which the compound 
was above the limit of quantification (LOQ) in either tissue. Each symbol 
represents results for one individual.   The line shows the expected 
relationship if concentrations in the two types of tissue had been equal. 
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Appendix Figure S2. 636 
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 646 
Figure S2. Concentrations (mg kg-1) of nimesulide in samples of kidney 
and liver tissue from the same bird for all five vultures in which the 
compound was above the limit of quantification (LOQ) in either tissue. 
Each symbol represents results for one individual.   The line shows the 
expected relationship if concentrations in the two types of tissue had been 
equal. 
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